Blog

An official partnership between AORTIC and ESHO

Photo from ESHO/LinkedIn

Aug 5, 2024, 18:28

An official partnership between AORTIC and ESHO

ESHO (Ethiopian Society of Hematology and Oncology) shared a post on LinkedIn:

”An official partnership is established! AORTIC and ESHO.

The two presidents signed an MOU that cemented the bilateral cooperation between the two organizations!”

ESHO

Source: ESHO/LinkedIn

AORTIC cancer ESHO Ethiopian Society of Hematology and Oncology OncoDaily Oncology

Oncologist Near Me - Vivek Subbiah: Pionner of Precision Oncology

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Special Coverage

ESMO 2024 Congress
September 13-17, 2024
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023

Facebook

RSS Feed

Youtube

Career

Jan 16, 2025, 14:06

Antonio Gualberto: I’m starting a new position as Global Head, Due Diligence Oncology at EMD Serono

Blog

Jan 16, 2025, 13:56

Miriam Mutebi: Stories like Claire’s haunt us as clinicians

Blog

Jan 16, 2025, 13:39

NHS England starts sending bowel cancer screening tests to over-50s

Blog

Jan 16, 2025, 13:38

Justin Stebbing: Princess of Wales "in remission" from cancer

Career

Jan 16, 2025, 13:33

Daniel Mckenzie: Started my role at KidzCan Zimbabwe as an Executive Director

Science

Jan 16, 2025, 13:29

Chang-il Hwang: How organoid technology is transforming pancreatic cancer research

Blog

Jan 16, 2025, 13:22

Prisca Githuka: I rang the bell at the finish line after 10 years of being on Cancer hormonal treatment

Blog

Jan 16, 2025, 13:21

Akhil Santhosh: Prevention of dermatologically adverse events with amivantamab combinations

Radiotherapy

Jan 16, 2025, 13:14

What Is Palliative Radiotherapy and How It Works? Pros and Cons

Opinion

Jan 16, 2025, 13:08

Amol Akhade: OS difference in first line Cdk inhibitors plus AI, amongst Palbociclib, Ribociclib and abemaciclib in MBC

Blog

Jan 16, 2025, 12:53

International Pediatric Onco-Critical Care Symposium

Blog

Jan 16, 2025, 12:46

Explore the latest in lung cancer care at TexasLung25 - IDEOlogy Health